Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression
Authors:
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 15 (3) , 383-391
Abstract
No abstract availableKeywords
Funding Information
- Bayer
- Boehringer Ingelheim
- Astellas Pharma
- Genentech
- Takeda Pharmaceutical Company
- Ipsen
- GlaxoSmithKline
- Janssen Pharmaceutica
- Novartis
- Agios Pharmaceuticals
- AbbVie
- Daiichi-Sankyo
- AstraZeneca
- Meso Scale Diagnostics
- Eisai
- Bristol-Myers Squibb
- Gilead Sciences
- Clovis Oncology
- Eli Lilly and Company
- Spectrum Pharmaceuticals
- Tizona Therapeutics
- Pfizer
- Celgene
- Astellas Pharma US
- Merck KGaA
- Roche
- Exelixis
- Amgen
- Sanofi
- Chugai Pharmaceutical
This publication has 31 references indexed in Scilit:
- Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment eraCancer Treatment Reviews, 2017
- EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastasesCancer Chemotherapy and Pharmacology, 2016
- Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer: Results From PROFILE 1014Journal of Clinical Oncology, 2016
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaNature Communications, 2015
- Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain MetastasesJournal of Clinical Oncology, 2015
- Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancersLung Cancer, 2015
- Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitorCancer, 2013
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall‐cell lung cancerCancer, 2010
- Detection and quantification of mutations in the plasma of patients with colorectal tumorsProceedings of the National Academy of Sciences, 2005